{"id":40152,"date":"2012-05-23T15:11:51","date_gmt":"2012-05-23T20:11:51","guid":{"rendered":""},"modified":"2026-02-18T16:28:38","modified_gmt":"2026-02-18T21:28:38","slug":"colorectal-cancer-screening-sigmoidoscopy-supplement2","status":"publish","type":"topics","link":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-cancer-screening-sigmoidoscopy-supplement2\/","title":{"rendered":"D\u00e9pistage du cancer colorectal : 2<sup>e<\/sup> suppl\u00e9ment au 2<sup>e<\/sup> m\u00e9moire de surveillance du groupe d\u2019experts en sigmo\u00efdoscopie flexible (2012)"},"content":{"rendered":"<p>Ce document fournit les r\u00e9sultats du quatri\u00e8me essai international sur la sigmo\u00efdoscopie flexible (essai PLCO [<em>Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial<\/em>] sur le d\u00e9pistage du cancer colorectal et des cancers de la prostate, du poumon et de l\u2019ovaire) portant sur les taux de mortalit\u00e9 \u00e0 long terme dans un contexte de d\u00e9pistage.<\/p>\n<p>Il s\u2019agit du deuxi\u00e8me suppl\u00e9ment au deuxi\u00e8me m\u00e9moire de surveillance sur la sigmo\u00efdoscopie flexible (lien). Ce suppl\u00e9ment peut \u00eatre utilis\u00e9 par les organismes provinciaux de lutte contre le cancer pour mettre les r\u00e9sultats de l\u2019essai en contexte avec le nombre de d\u00e9c\u00e8s provenant des trois autres essais internationaux sur la sigmo\u00efdoscopie flexible. Apr\u00e8s la publication de ce document, un m\u00e9moire de surveillance exhaustif comprenant tous les r\u00e9sultats des essais randomis\u00e9s sur la sigmo\u00efdoscopie flexible sera distribu\u00e9.<\/p>\n<p>Les r\u00e9sultats publi\u00e9s des essais des \u00c9tats-Unis, du Royaume-Uni, de l\u2019Italie et de la Norv\u00e8ge montrent clairement que le d\u00e9pistage par sigmo\u00efdoscopie flexible r\u00e9duit la fr\u00e9quence du cancer colorectal et les d\u00e9c\u00e8s dus \u00e0 ce cancer chez les personnes pr\u00e9sentant un risque moyen.<\/p>\n<div class=\"related-stats orange col-sm-12 col-md-12 col-lg-12 display-left\"><div class=\"stats-header\">26 %<\/div>   <div class=\"stats-sub-header\">diminution significative des d\u00e9c\u00e8s dus au cancer colorectal selon l'\u00e9tude PLCO<\/div>\n                    <\/div>\n<p>L\u2019\u00e9tude PLCO a fait \u00e9tat d\u2019une diminution significative des d\u00e9c\u00e8s dus au cancer colorectal (26\u00a0%) et de la fr\u00e9quence de ce cancer (21\u00a0%) dans le groupe de patients \u00e2g\u00e9es de 55 \u00e0 74\u00a0ans pr\u00e9sentant un risque moyen et chez qui on avait proc\u00e9d\u00e9 \u00e0 un d\u00e9pistage. Les r\u00e9sultats de trois\u00a0essais montrent une diminution statistiquement significative de la fr\u00e9quence du cancer colorectal et deux des\u00a0essais ont relev\u00e9 des diminutions statistiquement significatives des d\u00e9c\u00e8s dus \u00e0 ce cancer.<\/p>\n<p>La sigmo\u00efdoscopie flexible pour le d\u00e9pistage du cancer colorectal doit \u00eatre envisag\u00e9e comme une option dans les programmes organis\u00e9s de d\u00e9pistage au Canada. La recherche de sang occulte dans les selles est d\u00e9j\u00e0 utilis\u00e9e comme principal test de d\u00e9pistage du programme.<\/p>\n<p><strong>Document \u00e0 t\u00e9l\u00e9charger <\/strong>(en anglais seulement)<\/p>\n<div class=\"documents col-md-12\"><div>\n                                <i class=\"fas fa-file-pdf document-icon\"><\/i>\n                                <div class=\"document-details\">\n                                    <a href=\"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2019\/01\/Flex-Sigmoid-2Supplement-EN.pdf\" target=\"_blank\">Flexible sigmoidoscopy: Second supplement to second watching brief<\/a><p class=\"file-information\">Taille du fichier 436 KB<\/p>         <\/div>\n                            <\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Ce document fournit les r\u00e9sultats du quatri\u00e8me essai international sur la sigmo\u00efdoscopie flexible (essai PLCO [Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial] sur le d\u00e9pistage du cancer colorectal et des cancers de la prostate, du poumon et de l\u2019ovaire) portant sur les taux de mortalit\u00e9 \u00e0 long terme dans un contexte de d\u00e9pistage. Il [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":0,"parent":0,"menu_order":0,"template":"","topics_tags":[],"type-of-care":[],"cancer-continuum":[1647],"cancer-system-measurement":[],"dbt-cancer-site":[475],"dbt-risk-factors":[],"dbt-population-characteristics":[],"class_list":["post-40152","topics","type-topics","status-publish","hentry","cancer-continuum-screening-fr","dbt-cancer-site-dbv-colorectal-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Canadian Partnership Against Cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40152\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"D\u00e9pistage du cancer colorectal : 2e suppl\u00e9ment au 2e m\u00e9moire de surveillance du groupe d\u2019experts en sigmo\u00efdoscopie flexible (2012) - Canadian Partnership Against Cancer\" \/>\n<meta property=\"og:description\" content=\"Ce document fournit les r\u00e9sultats du quatri\u00e8me essai international sur la sigmo\u00efdoscopie flexible (essai PLCO [Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial] sur le d\u00e9pistage du cancer colorectal et des cancers de la prostate, du poumon et de l\u2019ovaire) portant sur les taux de mortalit\u00e9 \u00e0 long terme dans un contexte de d\u00e9pistage. Il [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&amp;p=40152\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Partnership Against Cancer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-18T21:28:38+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@cancerstratca\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/?post_type=topics&p=40152\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/?post_type=topics&p=40152\",\"name\":\"D\u00e9pistage du cancer colorectal : 2e suppl\u00e9ment au 2e m\u00e9moire de surveillance du groupe d\u2019experts en sigmo\u00efdoscopie flexible (2012) - Canadian Partnership Against Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\"},\"datePublished\":\"2012-05-23T20:11:51+00:00\",\"dateModified\":\"2026-02-18T21:28:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/?post_type=topics&p=40152#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/?post_type=topics&p=40152\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/?post_type=topics&p=40152#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Topics\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/topics\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"D\u00e9pistage du cancer colorectal : 2e suppl\u00e9ment au 2e m\u00e9moire de surveillance du groupe d\u2019experts en sigmo\u00efdoscopie flexible (2012)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\",\"url\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/\",\"name\":\"Canadian Partnership Against Cancer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Partnership Against Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40152","og_locale":"fr_FR","og_type":"article","og_title":"D\u00e9pistage du cancer colorectal : 2e suppl\u00e9ment au 2e m\u00e9moire de surveillance du groupe d\u2019experts en sigmo\u00efdoscopie flexible (2012) - Canadian Partnership Against Cancer","og_description":"Ce document fournit les r\u00e9sultats du quatri\u00e8me essai international sur la sigmo\u00efdoscopie flexible (essai PLCO [Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial] sur le d\u00e9pistage du cancer colorectal et des cancers de la prostate, du poumon et de l\u2019ovaire) portant sur les taux de mortalit\u00e9 \u00e0 long terme dans un contexte de d\u00e9pistage. Il [&hellip;]","og_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40152","og_site_name":"Canadian Partnership Against Cancer","article_publisher":"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/","article_modified_time":"2026-02-18T21:28:38+00:00","twitter_card":"summary_large_image","twitter_site":"@cancerstratca","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40152","url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40152","name":"D\u00e9pistage du cancer colorectal : 2e suppl\u00e9ment au 2e m\u00e9moire de surveillance du groupe d\u2019experts en sigmo\u00efdoscopie flexible (2012) - Canadian Partnership Against Cancer","isPartOf":{"@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website"},"datePublished":"2012-05-23T20:11:51+00:00","dateModified":"2026-02-18T21:28:38+00:00","breadcrumb":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40152#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40152"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40152#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Topics","item":"https:\/\/www.partnershipagainstcancer.ca\/topics\/"},{"@type":"ListItem","position":2,"name":"D\u00e9pistage du cancer colorectal : 2e suppl\u00e9ment au 2e m\u00e9moire de surveillance du groupe d\u2019experts en sigmo\u00efdoscopie flexible (2012)"}]},{"@type":"WebSite","@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website","url":"https:\/\/dev.partnershipagainstcancer.ca\/","name":"Canadian Partnership Against Cancer","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.partnershipagainstcancer.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/40152","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics"}],"about":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/types\/topics"}],"author":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/users\/24"}],"wp:attachment":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/media?parent=40152"}],"wp:term":[{"taxonomy":"topics_tags","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics_tags?post=40152"},{"taxonomy":"type-of-care","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/type-of-care?post=40152"},{"taxonomy":"cancer-continuum","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-continuum?post=40152"},{"taxonomy":"cancer-system-measurement","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-system-measurement?post=40152"},{"taxonomy":"dbt-cancer-site","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-cancer-site?post=40152"},{"taxonomy":"dbt-risk-factors","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-risk-factors?post=40152"},{"taxonomy":"dbt-population-characteristics","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-population-characteristics?post=40152"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}